SUNNYVALE, Calif., April 11, 2019 /PRNewswire/ -- ClearLight Biotechnologies, LLC announced today the publication of theirfirst peer-reviewed manuscript in collaboration with authors, Sunil Badve, M.D. and Yesim Gokmen-Polar, Ph.D. Current technologies utilized for preclinical and clinical drug development in cancer are largely dependent upon
"By partnering with the team at the Indiana University's Melvin and Bren Simon Cancer Center, we have been able to work with world renowned experts in the clinical and translational field, while greatly advancing our platform development program," commented Laurie Goodman, Ph.D. Chief Executive Officer at ClearLight Biotechnologies. "We look forward to future collaborative work to establish the clinical utility of the technology."
Direct link to manuscript: https://rdcu.be/buB5j
About ClearLightFounded by Karl Deisseroth M.D., Ph.D., ClearLight is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University. This technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The process produces a fully assembled, intact tissue, which is permeable to macromolecules and optically transparent, thus allowing for robust three-dimensional imaging of subcellular components (DNA, RNA and protein) and analysis of heterogeneous cellular interactions within the microenvironment of a tissue. This technology, paired with proprietary 3D image analysis software, will enable more accurate analysis and assessment of normal and diseased tissue.
Please visit and follow us at:Website: www.clearlightbiotechnologies.comLinkedIn: https://www.linkedin.com/in/clearlight-biotechnologies-llc-ab0970172/Twitter: https://twitter.com/ClearlightBioYouTube: https://www.youtube.com/channel/UCXKptXdwz68uZEo8Z-CiRsw
Contact: Laurie Goodman, Ph.D., CEO212562@email4pr.com(800) 251-8905
View original content:http://www.prnewswire.com/news-releases/clearlight-biotechnologies-and-researchers-at-the-indiana-universitys-melvin-and-bren-simon-cancer-center-announce-the-publication-of-three-dimensional-imaging-and-quantitative-analysis-in-clarity-processed-breast-cancer-tissues-300830057.html
SOURCE ClearLight Biotechnologies
Subscribe to our Free Newsletters!